Ascending Single Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Desvenlafaxine Succinate Sustained Release Administered Orally to Healthy Chinese Subjects.

Trial Profile

Ascending Single Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Desvenlafaxine Succinate Sustained Release Administered Orally to Healthy Chinese Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 28 Jan 2013

At a glance

  • Drugs Desvenlafaxine (Primary)
  • Indications Depressive disorders; Vasomotor symptoms
  • Focus Adverse reactions
  • Sponsors Wyeth
  • Most Recent Events

    • 11 Jul 2009 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
    • 16 Jan 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top